Salesforce (CRM)
Executive Summary & Action Plan
Verdict
BUY — The first BUY of our 18-name AI value-chain sweep, and the market is paying us to take it: at $163 the reverse-DCF implies ~1.8% perpetual growth — below inflation — for a franchise guiding +11%, compounding Agentforce at +205%, printing record margins, and repurchasing 11% of its shares. Even our structured bear case ($184) sits above the tape. The SaaSpocalypse priced a catastrophe the Q1 evidence contradicts.
Price $163.32 | Market cap $133.8B | Target $220 | Upside +34.7% IWANNAVY Fair Value · price as of 2026-07-11 close · Street consensus $245.60 (reference; n=52, +50.4% — the largest positive gap in our sweep) — we sit below Street only because we expense SBC and charge the new $1.3B interest bill; our stale 5/18 mark of $246 is trimmed to $220 on the same discipline
Abstract
Salesforce is the deep-value expression of the agent era's central question: do AI agents route around the system of record, or monetize through it? The Q1 FY27 evidence favors "through": Agentforce ARR tripled to $1.2B with >50% of bookings from existing customers, 28.6T tokens and 3.8B agentic work units processed, Sales and Service posted seat GROWTH with premium-SKU bookings +60%, attrition fell — and the attach was margin-accretive, with non-GAAP operating margin at a record 34.8%. The honest caveats: organic growth is ~8.7% (Informatica adds ~3pts), the new two-bucket disclosure blurs cloud-level comparability, and the balance sheet now carries $30.7B of net debt — mostly the $25B notes that funded the largest-ever ASR, whose ~$1.3B interest bill is why FCF-growth guidance halved. Our $220 fair value is the log-median of an SBC-expensed DCF ($308), 14x forward FCF ($220), and 14x forward EBITDA ($199); every cell of the DCF sensitivity grid sits above spot. Rating: BUY — accumulate here and at $150; the late-August print and Dreamforce (9/15–17) are the re-rating catalysts.
Action Plan
Position now; the −40% de-rate has already reset the bar. Accumulate $163 (market) and $150 (52w-low zone); first target $199, second $220; core runner to $246 (Street/stale-mark zone). Stop for traders $138.
- Risk/Reward ~4.3:1 at market (to FV vs value-trap floor) | Prob-weighted 12M return +37.8% (Bull 20% × +125% + Base 45% × +34.7% + Bear 35% × −8.2%) | Confidence: Medium-High
Last Four Quarters
Fiscal quarters (FYE January). Revenue $10.24B → $11.13B with GAAP operating margin holding 19–24% — real profitability net of ~8% SBC, unique in our software cohort. FCF is violently seasonal (fiscal-Q1 collections: 58.9% margin); the run-rate read is the FY26 total ($14.4B) growing ~4–5% under the new interest bill. The Q1 GAAP EPS "+52%" needs cleaning: $558M of investment gains (+$0.49) and the ASR share-count boost (+$0.14) flattered it.
Revenue & Profit Mix
FY27 brought a deliberate disclosure reset: the five-cloud split is gone, replaced by "Agentforce Apps" ($6.91B, +8.9% — the honest read on legacy seat growth) and "Data 360, headless platform & other" ($3.68B, +24.7% headline / ~+10% organic ex-Informatica). Q1 FY27 per the 5/27 release.
Business Lines
- Agentforce Apps (~62% of revenue, +8.9%): The seat-based core. Must know — seats are not shrinking, they are being up-tiered: Sales and Service grew seats YoY with premium A1E/A4X bookings +60%; but this bucket's single-digit growth is the honest pulse of legacy CRM, and the new disclosure blends Agentforce uplift into it.
- Data 360 & platform (~33%, ~+10% organic): Data Cloud + Informatica + MuleSoft + Zero Copy (35T records, +277%). Must know — this is the moat argument monetized: the trusted-context layer agents must query; Informatica drove the Q1 beat via lumpy on-prem license revenue — watch organic, and Tableau softness inside the bucket.
- Agentforce ($1.2B ARR, +205% — the swing line): Consumption-metered (Flex Credits, ~$0.10/action). Must know — margin-accretive at record OM in the same quarter it tripled, refuting the dilution bear point; at ~3% of revenue it is a narrative swing factor, not yet a financial one. Dreamforce tells whether consumption accelerates H2 organic as guided.
- Professional services (~5%): Must know — Q1 benefited from "services timing" per the CFO — a low-quality beat component; don't extrapolate.
IWANNAVY Fair Value
Log-median lands at $220. The construction is deliberately conservative — SBC fully expensed (8.2% of revenue, best hygiene in the cohort, with the unrecognized-grant schedule stepping down), the new $1.3B interest bill charged, Informatica stripped from organic — and the entire base-path sensitivity grid ($265–368) still clears spot. The multiples legs ($199–220) are what cap the target, not the DCF.
- Thesis breaker (for the BUY): cRPO growth <11% or another organic-guide trim at the late-August print — the seat-compression tripwire that converts value into value trap ($150–175 zone); an Agentforce deceleration below +100% YoY by Q4 FY27, or a Dreamforce consumption-pricing reveal that reads defensive, freezes the re-rate at ~10–11x EV/FCF.
Catalysts & Risks
References
- Salesforce Q1 FY27 results — Agentforce $1.2B ARR, record margins, FY27 guide (IR/8-K, 2026-05-27) · Q1 FY27 10-Q (SEC) — SBC $880M, cRPO $33.6B, new segment disclosure · CNBC — beats but guidance light (2026-05-27)
- Yahoo — 52-week low after 14 straight down sessions (2026-06-22) · Guggenheim upgrade — bear case a "hallucination" (2026-06-26) · MLQ — software surges as AI-disruption fears ease (2026-06-26)
- $25B senior notes (priced 3/11/26, 8 tranches 4.50–6.70%) funding the $25B ASR (launched 3/16/26, ~103M shares) — 8-K filings · Informatica closed 2025-11-18 (~$8B, $6B term loans)
면책사항 · 본 IC 메모는 IWANNAVY LAB의 내부 투자 리서치 자료이며, 공개된 정보와 에이전트 기반 분석을 종합한 교육·연구 목적 문서입니다. 투자 권유·매수/매도 추천이 아니며, 모든 투자 판단과 책임은 투자자 본인에게 있습니다. 가격 데이터는 yfinance + Finviz Elite 교차검증으로 2026-07-12 기준이며, 시장 동향에 따라 실시간 변동할 수 있습니다.
Comments are public. Posting is limited to paid members.
Posting is available on LAB Pro
Sign in, then upgrade to join the discussion.
Loading comments...